or
forgot password
  • cancer clinical trials in stanford, CA

  • Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Stanford Cancer Center
    Stanford, California 94305-5824
    Thyroid Cancer
    Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pilomatrixoma
    Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Invasive Thymoma and Thymic Carcinoma, Recurrent Thymoma and Thymic Carcinoma, Stage III Thymoma, Stage IVA Thymoma, Stage IVB Thymoma
    A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
    Stanford Comprehensive Cancer Center
    Stanford, California 94305
    Myelofibrosis
    Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Neoplasms
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
    Stanford University
    Stanford, California 94305
    Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Prostate Active Surveillance Study
    Stanford University
    Stanford, California 94305
    Prostatic Neoplasms
    A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Graft vs Host Disease
    Permission to Collect Blood Over Time for Research
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Pancreatic Cancer, Gastrointestinal Neoplasms, Colon Rectal Cancer Adenocarcinoma, Esophageal Cancer, Gall Bladder Cancer, Gastric (Stomach) Cancer, Gastrooesophageal Cancer, Gastrointestinal Stromal Tumor (GIST), Hepatobiliary Neoplasm, Liver Carcinoma, Gallbladder Carcinoma, Bile Duct Carcinoma, Carcinoma of the Large Intestine, Anal Cancer
    Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Liver Cancer, Hepatitis B, Hepatitis C, Hepatobiliary Cancers Liver, Hepatobiliary Cancers
    An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
    Stanford Cancer Center
    Stanford, California 94305-5824
    Carcinoid Syndrome
    Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction, Gastrointestinal Stromal Tumor (GIST)
    Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
    Stanford University Medical Center Stanford University 2
    Stanford, California 94305-5750
    Leukemia
    A Study of Nilotinib Versus Imatinib in GIST Patients
    Stanford University Medical Center Stanford Cancer Center
    Stanford, California 94304
    Gastrointestinal Stromal Tumor (GIST)
    Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
    Site Reference ID/Investigator# 9782
    Stanford, California 94305
    CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematological Malignancies, Non-Hodgkin's Lymphoma
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
    Stanford Comprehensive Cancer Center
    Stanford, California 94305
    Triple Negative Breast Cancer
    Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
    Stanford Cancer Center
    Stanford, California 94305-5824
    Precancerous Condition
    A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Disease, Hodgkin
    OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome
    Stanford University
    Stanford, California 94305
    Sepsis, Acute Lung Injury, Acute Respiratory Distress Syndrome
    A Phase II Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lymphoma, Non-Hodgkin, Lymphoma, Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell, Lymphomas: Non-Hodgkin
    F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
    Stanford University Medical Center
    Stanford, California 94305-5408
    Bone Metastases
    Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain Cancer, Pediatric Cancers
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Stanford University
    Stanford, California 94305
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
    Stanford University Cancer Institute
    Stanford, California 94305
    Leukemia, Amyloidosis
    Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
    Stanford University
    Stanford, California 94305
    Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    Intellectual Impairment in Women With Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer
    Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Cutaneous T-cell Lymphoma
    DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
    Stanford University Medical Center
    Stanford, California 94305-5408
    Brain Tumors, Central Nervous System Tumors
    Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
    Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC
    Stanford University Medical Center
    Stanford, California 94305-5408
    Hepatocellular Carcinoma
    MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
    Stanford University Medical Center
    Stanford, California 94305-5408
    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Brain Cancer, Neoplasm Metastasis, Cancer of Brain and Nervous System, Metastatic Malignant Neoplasm to Brain
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    Stanford University Medical Center
    Stanford, California 94305-5408
    Multiple Sclerosis, Relapsing-Remitting
    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
    Stanford University Medical Center
    Stanford, California 94305-5408
    Solid Tumors, Cancer
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    Stanford University Medical Center Division of Hematology 2
    Stanford, California 94304
    Myelodysplastic Syndromes
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Brain Cancer, Neoplasm Metastasis, Lung Cancer, Carcinoma, Non-Small-Cell Lung
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Stanford University Hospitals and Clinics
    Stanford, California 94305
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Treatment of Blood Clots in Children With Cancer
    Stanford University Medical Center
    Stanford, California 94305-5408
    Venous Thromboembolism
    Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
    Stanford University Medical Center SC
    Stanford, California 94304
    Pancreatic Neoplasm, Pituitary Neoplasm, Nelson Syndrome, Ectopic ACTH Syndrome
    Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Stanford University
    Stanford, California 94305
    Relapsed or Refractory Chronic Lymphocytic Leukemia
    Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
    Stanford Cancer Institute
    Stanford, California 94305
    Non-small Cell Lung Cancer
    ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
    Stanford University Medical Center
    Stanford, California 94305-5408
    Bone Metastases
    Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
    Stanford University Medical Center
    Stanford, California 94305-5408
    Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
    Management of Insomnia in Breast Cancer Patients
    Stanford University
    Stanford, California 94305
    Insomnia, Fatigue
    Combination SBRT (Stereotactic Body Radiotherapy) With TACE (Transarterial Chemoembolization) for Unresectable Hepatocellular Carcinoma
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Carcinoma, Hepatocellular, Hepatobiliary Neoplasm, Liver Carcinoma
    Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma
    Stanford University Medical Center School of Medicine
    Stanford, California 94304
    Multiple Myeloma
    Overcoming Obstacles to Clinical Trials Enrollment Through a Navigator Program
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Genital Neoplasms, Female, Gynecologic Cancers, Breast Cancer
    Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer
    4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Lung Cancer
    Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Anemia, Leukemia, Leukemia, Myelocytic, Acute, Dysmyelopoietic Syndromes
    Magnetic Resonance Imaging of Breast Cancer
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Breast Cancer, Breast Cancer Non-invasive Breast Cancer
    Genomic Analysis of Pediatric Bone Tumors
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Bone Cancer
    Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure
    Stanford University School of Medicine
    Stanford, California 94305-5317
    Brain Cancer, Cancer